Empagliflozin: medicines on 13 registers | Prognia

Skip to content

Loading your page…

All medicines with Empagliflozin

Every register, a page at a time. Strengths and packs are on each medicine’s page.

18 results

Medicine	Register	Strength	Form	Status	Holder
Empagliflozin	United States	10MG, 2.5MG	tablet	Tentative approval	Aurobindo Pharma Limited
Empagliflozin	United States	10MG, 2.5MG, 25MG	tablet	Tentative approval	Zydus Pharms
Empagliflozin and Metformin HydrochlorideCombination	United States	12.5MG; 1GM, 12.5MG; 500MG, 5MG; 1GM …	tablet	Not marketed	Zydus Pharms
Empagliflozin; LinagliptinCombination	United States	10MG; 5MG, 10MG/5MG, 25MG; 5MG …	tablet	Tentative approval	Annora Pharma
Empagliflozin and LinagliptinCombination	United States	10MG; 5MG, 25MG; 5MG	tablet	Tentative approval	Prinston Pharma INC
Empagliflozin; Metformin HydrochlorideCombination	United States	12.5MG; 1000MG, 12.5MG; 500MG, 5MG; 1000MG …	tablet	Tentative approval	Macleods Pharms LTD
Empagliflozin;Metformin HydrochlorideCombination	United States	10MG; 1GM, 12.5MG; 1GM, 25MG; 1GM …	tablet, extended release	Tentative approval	Lupin LTD
Empagliflozin Metformin HydrochlorideCombination	United States	10MG/1000MG, 12.5MG/1000MG, 25MG/1000MG …	tablet, extended release	Tentative approval	MSN Labs PVT LTD
Empagliflozin; Metformin HydrochlorideCombination	United States	5MG; 1000MG	tablet, extended release	Tentative approval	Cipla LTD
Empagliflozin and Metformin HydrochlorideCombination	United States	10MG/1000MG, 12.5MG/1000MG, 25MG/1000MG …	tablet, extended release	Tentative approval	Ajanta Pharma LTD
Empagliflozin; Linagliptin; Metformin HydrochlorideCombination	United States	10MG; 5MG; 1000MG, 12.5MG; 2.5MG; 1000MG, 25MG; 5MG; 1000MG …	tablet, extended release	Tentative approval	Zydus Pharms USA INC
GlyxambiCombination	United States	10MG; 5MG, 25MG; 5MG	tablet	Marketed	Boehringer Ingelheim
Jardiance	United States	10MG, 25MG	tablet	Marketed	Boehringer Ingelheim
SynjardyCombination	United States	12.5MG; 1GM, 12.5MG; 500MG, 5MG; 1GM …	tablet	Marketed	Boehringer Ingelheim
Synjardy XRCombination	United States	10MG; 1GM, 12.5MG; 1GM, 25MG; 1GM …	tablet, extended release	Marketed	Boehringer Ingelheim
Trijardy XRCombination	United States	10MG; 5MG; 1GM, 12.5MG; 2.5MG; 1GM, 25MG; 5MG; 1GM …	tablet, extended release	Marketed	Boehringer Ingelheim
Dapagliflozin	United States	10MG, 5MG	tablet	Marketed	Jiangsu Hansoh Pharm
Dapagliflozin	United States	10MG, 5MG	tablet	Tentative approval	Centaur Pharmaceuticals Private Limited